SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kropotova Alexandra
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Eddie Joe
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King Michael
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Samuel J
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)
SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%), etc.
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 424B5: Prospectus
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | DEF 14A: Definitive information statements
SAB Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Sullivan Eddie Joe
SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
No Data